Benchling for Antibody Therapeutics R&D

This application note outlines the critical needs and complexities faced during antibody discovery and development and how Benchling has helped address these challenges for leading antibody companies.


Antibodies are an important class of therapeutic agents which have evolved significantly over the past 30 years. Antibody R&D is now more streamlined than ever, but several factors continue to contribute to its complexity.

This application note provides:

  • An outline of the complexities present in antibody research and development

  • How Benchling’s capabilities can solve these complexities

Read application note

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image